TRANSCODE THERAPEUTICS, INC. (RNAZ) Operating cash flow 2020–2025
TRANSCODE THERAPEUTICS, INC. (RNAZ) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$19.5MFY2025 · since FY2020: -$492,971 → -$19.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$19.5M | -46.3% |
| FY2024 | -$13.3M | +26.2% |
| FY2023 | -$18.1M | -14.7% |
| FY2022 | -$15.8M | -199.3% |
| FY2021 | -$5.3M | -968.4% |
| FY2020 | -$492,971 | — |
Source: SEC XBRL filings · For reference only · Not investment advice